ReviewJournal for immunotherapy of cancer2019

Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions.

Marc Hilmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.